Table 2.
Differences in Changes of Mean Adherence Rates From M1 to M2
| Control Hospitals (n=19) | Intervention Hospitals (n=19) | |||||||
|---|---|---|---|---|---|---|---|---|
| M1 | M2 | Difference, % | P | M1 | M2 | Difference, % | P | |
| ACE inhibitors | 59.29 | 57.66 | −1.63 | NS | 71.06 | 64.11 | −6.95 | 0.01 |
| Lipid-lowering therapy | 83.46 | 88.61 | 5.15 | 0.02 | 91.28 | 92.96 | 1.68 | NS |
| Clopidogrel | 54.30 | 67.24 | 12.94 | <0.01 | 73.73 | 78.99 | 5.26 | 0.09 |
| Heparin/LMWH | 72.07 | 84.38 | 12.31 | <0.01 | 83.66 | 88.08 | 4.42 | 0.07 |
| Coronary angiography | 55.27 | 63.69 | 8.42 | 0.01 | 72.29 | 70.66 | −1.63 | NS |
ACE indicates angiotensin-converting enzyme; LMWH, low-molecular-weight heparin.